Chemical Biology 2012

•Summary
Chemical Biology is a quickly growing highly interdisciplinary field, which investigates biological questions by using chemical strategies and tools. It has emerged to become an important and central discipline by itself complementing areas such as medicinal chemistry, pharmacology, cell biology, structural biology and biochemistry. Researchers in Chemical Biology find themselves at home in the chemistry and the biology lab and fuse the experimental possibilities that both have to offer.

•Aims of event
The biennial series aims to give an overview on the current status of the fast evolving field and an outlook to where the field is heading. The conference will provide a unique opportunity for scientists using diverse research approaches and methods to come together and to network. It is structured to enhance exchange and discussions between researchers, for the benefit of their own research as well as for the progress of the field.

•Topics
The conference will cover a broad area of approaches and methods used in Chemical Biology including:

◦Molecular imaging and switching tools

◦Computational and structural approaches

◦Innovative drug design approaches

◦Chemical genetics and high throughput methods

◦Novel synthetic methods as applied to biological questions

◦Chemical protein engineering

◦Chemical cell biology



+ show speakers and program
Philippe Bastiaens, Max Planck Institute of Molecular Physiology, Germany


Christopher Lipinski, Melior Discovery, USA


Christopher T. Walsh, Harvard Medical School, USA


George M. Whitesides, Harvard University, USA


Confirmed Speakers
Annette G. Beck-Sickinger, University of Leipzig, Germany


H. Alex Brown, Vanderbilt University, USA


Søren Brunak, Technical University of Denmark and University of Copenhagen, Denmark


Jason W. Chin, Medical Research Council Laboratory of Molecular Biology, United Kingdom


Philip A. Cole, Johns Hopkins University School of Medicine, USA


Jonathan Ellman, Yale University, USA


Ronald Frank, Leibniz Institute for Molecular Pharmacology, Germany


Wolf B. Frommer, Carnegie Institution for Science, USA


Paul J. Hergenrother, University of Illinois, USA


Ludovic Jullien, École Normale Supérieure Paris, France


Tarun Kapoor, The Rockefeller University, USA


Derek Lowe, Vertex Pharmaceuticals, USA


Ronald Micura, Leopold Franzens University, Austria


Alanna Schepartz, Yale University, USA


Brian Shoichet, University of California at San Francisco, USA


David A. Tirrell, California Institute of Technology, USA


James A. Wells, University of California at San Francisco, USA


Helma Wennemers, Swiss Federal Institute of Technology Zurich, Switzerland


Paul Workman, The Institute of Cancer Research, United Kingdom


26 Sep - 29 Sep 2012
Heidelberg
Germany
meeting website